Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Hyalgan

Related Conditions

Often studied with 11 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Phase 2 (1)
Phase 4 (1)

Trial Status

Enrolling By Invitation1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • Hyalgan1
  • 028 Sodium Hyaluronate Preservative Free Eye Drops1
  • Hyajoint1
  • 018 Sodium Hyaluronate Preservative Free Eye Drops1

Active Sponsors

  • Kaohsiung Veterans General Hospital.1
  • Department of Medical Services Ministry of Public Health of Thailand1

Top Investigators

Related Conditions

  • Tear Breakup Time1
  • Dry Eye Disease Ded1
  • Knee1
  • Tear Film Insufficiency1
  • Dry Eye1

Activity Timeline